ANN ARBOR, Mich., April 15 /PRNewswire/ -- MedTrust Online, LLC has incorporated the NexCura(R) Cancer ProfilerTools from Thomson Reuters into www.oncocentric.com, a free portal that provides information tools and clinically useful content to help oncologists make the best treatment decisions for their patients.

"This collaboration is another important step in helping oncologists select the best therapies for their patients," said Chris Yoo, Ph.D., president and CEO of MedTrust Online. "We are excited to develop essential tools that enable doctors to realize precision medicine."

Doctors visiting www.oncocentric.com can access the latest scientific literature, confirm drug information, identify appropriate clinical trials, and narrow databases of knowledge based on disease presentation. The portal also shares the latest information from MedTrust Online's board of oncology experts about difficult-to-treat and rare cancers and provides a forum where doctors can discuss treatment options with experts and other oncologists. With NexCura's Profiler Tools integrated into the portal, doctors can conduct searches across multiple databases of clinical information and build profiles of cancer cases that require more involved investigation and present personalized treatment information for the patient.

"For the first time, several key sources of knowledge that doctors rely on and the everyday need to consult informally with colleagues and experts have been addressed in one simple-to-use interface," Dr. Yoo said.

Alicia Moffat, vice president of web operations for the Healthcare business of Thomson Reuters, said: "We are pleased to provide the NexCura Cancer Profiler Tools through portals like oncocentric.com that can make a meaningful impact on patient care. We see great promise and power in the combination of our high quality content and MedTrust Online's innovative search and collaboration platform."

About Thomson Reuters

The Healthcare business of Thomson Reuters produces insights, information, benchmarks and analysis that enable organizations to manage costs, improve performance and enhance the quality of healthcare. Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.

About MTOL

MedTrust Online LLC, www.medtrust-online.com, headquartered in Scottsdale, Arizona, provides oncologists with clinically useful technology applications and solutions. MedTrust Online brings together experts in Oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to capture, organize, analyze, integrate and present the most up-to-date medical facts from a vast array of sources. This data is provided to doctors in a comprehensive yet concise way unavailable anywhere else.

SOURCE  Thomson Reuters
    -0-                           04/15/2009
    /CONTACT:  David Wilkins, Media Relations, Healthcare, +1-734-913-3397,
david.wilkins@thomsonreuters.com/
    /Web Site:  http://www.thomsonreuters.com /
    (TRI)

CO:  Thomson Reuters; MedTrust Online, LLC

ST:  Michigan, Arizona
IN:  HEA NET WEB CPR
SU:  JVN PDT

PR
-- DE99465 --
5765 04/15/200913:28 EDThttp://www.prnewswire.com